Last10K.com

Aethlon Medical Inc (AEMD) SEC Filing 10-Q Quarterly report for the period ending Saturday, September 30, 2017

Aethlon Medical Inc

CIK: 882291 Ticker: AEMD
Document and Entity Information - shares
6 Months Ended
Sep. 30, 2017
Nov. 02, 2017
Document And Entity Information  
Entity Registrant NameAETHLON MEDICAL INC 
Entity Central Index Key0000882291 
Document Type10-Q 
Document Period End DateSep. 30, 2017 
Amendment Flagfalse 
Current Fiscal Year End Date--03-31 
Is Entity a Well-known Seasoned Issuer?No 
Is Entity a Voluntary Filer?No 
Is Entity's Reporting Status Current?Yes 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 15,095,867
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2018 

View differences made from one quarter to another to evaluate Aethlon Medical Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aethlon Medical Inc.

Continue

Assess how Aethlon Medical Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aethlon Medical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets (parenthetical)
Condensed Consolidated Balance Sheets (unaudited)
Condensed Consolidated Statements Of Cash Flows (unaudited)
Condensed Consolidated Statements Of Operations (unaudited)
1. Nature Of Business And Basis Of Presentation
1. Nature Of Business And Basis Of Presentation (details Narrative)
1. Nature Of Business And Basis Of Presentation (policies)
10. Warrants
10. Warrants (details - Assumptions)
10. Warrants (details - Warrant Activity)
10. Warrants (details Narrative)
10. Warrants (tables)
11. Darpa Contract And Related Revenue Recognition
11. Darpa Contract And Related Revenue Recognition (details Narrative)
12. Segments
12. Segments (details)
12. Segments (tables)
13. Commitments And Contingencies
13. Commitments And Contingencies (details Narrative)
14. Subsequent Events
2. Loss Per Common Share
2. Loss Per Common Share (details Narrative)
3. Research And Development Expenses
3. Research And Development Expenses (details)
3. Research And Development Expenses (tables)
4. Future Accounting Pronouncements
5. Convertible Notes Payable (details - Convertible Note Activity)
5. Convertible Notes Payable (details - Convertible Notes Payable)
5. Convertible Notes Payable (details Narrative)
5. Convertible Notes Payable (tables)
5. Convertible Notes Payable, Net
6. Equity Transactions
6. Equity Transactions (details Narrative)
7. Related Party Transactions
7. Related Party Transactions (details Narrative)
8. Other Current Liabilities
8. Other Current Liabilities (details)
8. Other Current Liabilities (tables)
9. Stock Compensation
9. Stock Compensation (details - Assumptions)
9. Stock Compensation (details - Option Activity)
9. Stock Compensation (details - Options Vested And Expected To Vest)
9. Stock Compensation (details - Rsu's Outstanding)
9. Stock Compensation (details - Share Based Compensation)
9. Stock Compensation (details Narrative)
9. Stock Compensation (tables)

Material Contracts, Statements, Certifications & more

Aethlon Medical Inc provided additional information to their SEC Filing as exhibits

Ticker: AEMD
CIK: 882291
Form Type: 10-Q Quarterly Report
Accession Number: 0001683168-17-002820
Submitted to the SEC: Thu Nov 02 2017 5:21:05 PM EST
Accepted by the SEC: Thu Nov 02 2017
Period: Saturday, September 30, 2017
Industry: Laboratory Analytical Instruments

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aemd/0001683168-17-002820.htm